Ausgabe 3/2023
Inhalt (25 Artikel)
Reirradiation versus systemic therapy versus combination therapy for recurrent high-grade glioma: a systematic review and meta-analysis of survival and toxicity
Ravi Marwah, Daniel Xing, Timothy Squire, Yu Yang Soon, Hui K. Gan, Sweet Ping Ng
Seizure outcomes after resection of primary brain tumors in pediatric patients: a systematic review and meta-analysis
Kalman A. Katlowitz, Prazwal Athukuri, Himanshu Sharma, Huy Dang, Astitva Soni, A. Basit Khan, Fatema Malbari, Nisha Gadgil, Howard L. Weiner
Age and sex disparities in Latin-American adults with gliomas: a systematic review and meta-analysis
Renée van′t Hek, Juan Luis Ortiz-Herrera, Alejandro Salazar-Pigeon, Cristopher Ramirez-Loera, Bernardo Cacho-Díaz, Talia Wegman-Ostrosky
Impact of timing of antiseizure medication withdrawal on seizure recurrence in glioma patients: a retrospective observational study
Pim B. van der Meer, Linda Dirven, Marta Fiocco, Maaike J. Vos, Melissa Kerkhof, Mathilde C.M. Kouwenhoven, Martin J. van den Bent, Martin J.B. Taphoorn, Johan A.F. Koekkoek
Supramaximal resection based on en-bloc technique reduces tumor burden and prolongs survival in primary supratentorial lobar glioblastoma
Tianshi Que, Guanglong Huang, Jian-er Tan, Peidong Zhang, Zhiyong Li, Guozhong Yi, Haojie Zheng, Xi Yuan, Xiang Xiao, Junlu Liu, Haiyan Xu, Xi-an Zhang, Songtao Qi
Sexually dimorphic effect of H-ferritin genetic manipulation on survival and tumor microenvironment in a mouse model of glioblastoma
Bhavyata Pandya Shesh, Vonn Walter, Kondaiah Palsa, Becky Slagle-Webb, Elizabeth Neely, Todd Schell, James R. Connor
Long-term clinical outcomes of stereotactic radiotherapy for bilateral vestibular schwannomas in neurofibromatosis type 2 patients
Putipun Puataweepong, Mantana Dhanacha, Rawee Ruangkanchanasetr, Keeratikarn Boonyawan, Ake Hansasuta, Kriangsak Saetia, Pornpan Yongvithisatid
Relationship between apparent diffusion coefficient and survival as a function of distance from gross tumor volume on radiation planning MRI in newly diagnosed glioblastoma
Pejman Jabehdar Maralani, James Stewart, Shivaprakash Hiremath, Liam Lawrence, Rachel Chan, Angus Lau, Hanbo Chen, Aimee Chan, Liang K. Zeng, Chia-Lin Tseng, Sten Myrehaug, Hany Soliman, Jay Detsky, Chinthaka Heyn, MaryJane Lim Fat, Nir Lipsman, Arjun Sahgal
Undetected pseudoprogressions in the CeTeG/NOA-09 trial: hints from postprogression survival and MRI analyses
Thomas Zeyen, Daniel Paech, Johannes Weller, Niklas Schäfer, Theophilos Tzaridis, Cathrina Duffy, Louisa Nitsch, Matthias Schneider, Anna-Laura Potthoff, Joachim Peter Steinbach, Peter Hau, Uwe Schlegel, Clemens Seidel, Dietmar Krex, Oliver Grauer, Roland Goldbrunner, Pia Susan Zeiner, Ghazaleh Tabatabai, Norbert Galldiks, Walter Stummer, Elke Hattingen, Martin Glas, Alexander Radbruch, Ulrich Herrlinger, Christina Schaub
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells
Johanna Vollmer, Jonas Ecker, Thomas Hielscher, Gintvile Valinciute, Johannes Ridinger, Nora Jamaladdin, Heike Peterziel, Cornelis M. van Tilburg, Ina Oehme, Olaf Witt, Till Milde
Intratumoral thrombosis as a histological biomarker for predicting epidermal growth factor receptor alteration and poor prognosis in patients with glioblastomas
Takuya Furuta, Tetsuya Negoto, Hiroaki Miyoshi, Mayuko Moritsubo, Hideo Nakamura, Motohiro Morioka, Jun Akiba, Koichi Ohshima, Yasuo Sugita
Treatment outcomes for response-based radiotherapy in children and adolescents with central nervous system germinoma: a prospective study
Chenggong Zeng, Qunying Yang, Zhuoran Li, Zhiqing Wei, Tingting Chen, Meiling Deng, Jian Wang, Juan Wang, Feifei Sun, Junting Huang, Suying Lu, Jia Zhu, Xiaofei Sun, Zijun Zhen
Risk of developing glioblastoma following non-CNS primary cancer: a SEER analysis between 2000 and 2018
David Y. A. Dadey, Zachary A. Medress, Mayur Sharma, Beatrice Ugiliweneza, Dengzhi Wang, Adrian Rodrigues, Jonathon Parker, Eric Burton, Brian Williams, Summer S. Han, Maxwell Boakye, Stephen Skirboll
RAI-measured frailty predicts non-home discharge following metastatic brain tumor resection: national inpatient sample analysis of 20,185 patients
Michael M. Covell, Akshay Warrier, Kranti C. Rumalla, Christopher M. Dehney, Christian A. Bowers
Advancing personalized prognosis in atypical and anaplastic meningiomas through interpretable machine learning models
Mert Karabacak, Pemla Jagtiani, Alejandro Carrasquilla, Raj K. Shrivastava, Konstantinos Margetis
Intraoperative or postoperative stereotactic radiotherapy for brain metastases: time to systemic treatment onset and other patient-relevant outcomes
Cas S. Dejonckheere, Julian P. Layer, Motaz Hamed, Katharina Layer, Andrea Glasmacher, Lea L. Friker, Anna-Laura Potthoff, Thomas Zeyen, Davide Scafa, David Koch, Stephan Garbe, Jasmin A. Holz, Fabian Kugel, Molina Grimmer, Frederic Carsten Schmeel, Gerrit H. Gielen, Helmut Forstbauer, Hartmut Vatter, Ulrich Herrlinger, Frank A. Giordano, Matthias Schneider, Leonard Christopher Schmeel, Gustavo R. Sarria
Characterizing T-cell dysfunction and exclusion signatures in malignant peripheral nerve sheath tumors reveals susceptibilities to immunotherapy
Archis R. Bhandarkar, Shaan Bhandarkar, Dusica Babovic-Vuksanovic, Ian F. Parney, Robert J. Spinner
Patterns and predictors of anxiety and depression symptom trajectories in patients diagnosed with primary brain tumors
Alayna E. Ernster, Anjelica Body, Phuong Deleyrolle, Jennifer St. Clair, Deborah Sampson, Kelsey Bacharz, Sandra C. Yan, Kaitlyn Melnick, Annie Allen, Maryam Rahman, David D. Tran, Duane A. Mitchell, Deidre B. Pereira, Ashley P. Ghiaseddin
Somatostatin receptor subtype expression and radiomics from DWI-MRI represent SUV of [68Ga]Ga-DOTATOC PET in patients with meningioma
Sarah Iglseder, Anna Iglseder, Vincent Beliveau, Johanna Heugenhauser, Elke R. Gizewski, Johannes Kerschbaumer, Guenther Stockhammer, Christian Uprimny, Irene Virgolini, Jozsef Dudas, Meinhard Nevinny-Stickel, Martha Nowosielski, Christoph Scherfler
The impact of opioid administration for post gamma knife radiosurgery frame removal: a prospective quality-improvement study
Jason Hsieh, Wei Wei, Jeffrey Z. Nie, Gene H. Barnett, Alireza M. Mohammadi, Glen Stevens, Michael Vogelbaum, Lilyana Angelov
Improved survival and intracranial tumor control of EGFR-mutated NSCLC patients with newly developed brain metastases following stereotactic radiosurgery and EGFR-TKI: a large retrospective cohort study and meta-analyses
Ai Seon Kuan, Chi-Lu Chiang, Hsiu-Mei Wu, Huai-Che Yang, Ching-Jen Chen, Chung-Jung Lin, Wan-Yuo Guo, David Hung-Chi Pan, Wen-Yuh Chung, Cheng-Chia Lee
The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis
Chelsea Kotch, Stephanie J. Si, Kavita Desai, Philippe Caminada, Francesco Maria Lo Russo, Yimei Li, Grant T. Liu, Robert A. Avery, Michael J. Fisher
The proneural subtype is not associated with survival benefit from bevacizumab in newly diagnosed glioblastoma: a secondary analysis of the GLARIUS trial
Johannes Weller, Thomas Zeyen, Niklas Schäfer, Christina Schaub, Anna-Laura Potthoff, Joachim P. Steinbach, Peter Hau, Clemens Seidel, Roland Goldbrunner, Ghazaleh Tabatabai, Hartmut Vatter, Theophilos Tzaridis, Matthias Schneider, Ulrich Herrlinger
Letter to the editor: the impact of systemic treatment on brain metastases should be considered in clinical outcome analysis
G. R. Borst, R. Post
Correction to: MiR-101-3p inhibits EMT to attenuate proliferation and metastasis in glioblastoma by targeting TRIM44
Ling Li, Mei-Ying Shao, Shu-Cheng Zou, Zhe-Feng Xiao, Zhu-Chu Chen